COVID-19 and Rhino-orbital Mucormycosis

Completed

• Conditions: Mucormycosis

• Registration Number: NCT05212961
• Lead Sponsor: Minia University

Brief Summary

Detect the clinical presentation and outcome of post covid-19 fungal mucormycosis in patients referred to Minia university Hospital.

Detailed Description

Not available

Study Timeline

• Study Start: 2021-12-28
• Study First Submitted: 2022-01-24
• Study First Submitted QC: 2022-01-24
• Study First Posted: 2022-01-28
• Primary Completion: 2023-06-28
• Study Completion: 2023-09-28
• Status Verified: 2023-10
• Last Update Submitted: 2023-10-17
• Last Update Posted: 2023-10-18

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

1. Patients who had positive PCR test for Covid-19.
2. Fungal rhino-orbital infection was confirmed.

Exclusion Criteria

1. Suspected patient with COVID-19 not confirmed with PCR
2. Incomplete data

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Outcome of rhino-orbital mucormycosis in COVID-19 patients	9 months	Data of the patients who had post Covid-19 fungal mucormycosis in the last year will be revised to detect clinical presentation and final outcome

Trial Locations

Locations (1)

Faculty of Medicine- Minia University; 🇪🇬 Minya, Egypt